BCAB vs ED · $5.9M cap vs P/E 18, rev $15.26B
Bioatla Inc (BCAB) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
BCAB currently screens at market cap $5.9M. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the BCAB and ED stock pages for the full models.
Not investment advice.